92 related articles for article (PubMed ID: 11385995)
1. [Inhibitors of proteolytic enzymes in the treatment of diabetes mellitus].
Valuev IL; Sytov GA; Valuev LI; Valueva TA; Ul'ianova MV; Platé NA
Vopr Med Khim; 2001; 47(1):132-9. PubMed ID: 11385995
[TBL] [Abstract][Full Text] [Related]
2. [Oral insulin preparations for the regulation of the glucose level in the blood].
Valuev LI; Sytov GA; Starosel'tseva LK; Valuev IL; Vanchugova LV; Valueva TA; Ul'ianova MV; Platé NA
Biomed Khim; 2009; 55(2):195-200. PubMed ID: 19507343
[TBL] [Abstract][Full Text] [Related]
3. Electroporation of polymeric nanoparticles: an alternative technique for transdermal delivery of insulin.
Rastogi R; Anand S; Koul V
Drug Dev Ind Pharm; 2010 Nov; 36(11):1303-11. PubMed ID: 20849347
[TBL] [Abstract][Full Text] [Related]
4. [Hypoglycemic effect of chitosan-microcapsulated insulin on the blood glucose level of streptozotocin-diabetic Wistar rats].
Huang H; Tian H; Li X; Zhao G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Sep; 18(3):425-7, 460. PubMed ID: 11605507
[TBL] [Abstract][Full Text] [Related]
5. Optimization and in vivo evaluation of an oral dual controlled-release tablet dosage form of insulin and duck ovomucoid.
Agarwal V; Nazzal S; Khan MA
Pharm Dev Technol; 2008; 13(4):291-8. PubMed ID: 18618331
[TBL] [Abstract][Full Text] [Related]
6. Formulation and characterization of an oily-based system for oral delivery of insulin.
Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
[TBL] [Abstract][Full Text] [Related]
7. The stability of insulin-loaded polybutylcyanoacrylate nanoparticles in an oily medium and the hypoglycemic effect in diabetic rats.
Hou ZQ; Zhang ZX; Xu ZH; Zhang H; Tong ZF; Leng YS
Yao Xue Xue Bao; 2005 Jan; 40(1):57-64. PubMed ID: 15881329
[TBL] [Abstract][Full Text] [Related]
8. Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin.
Damgé C; Vranckx H; Balschmidt P; Couvreur P
J Pharm Sci; 1997 Dec; 86(12):1403-9. PubMed ID: 9423155
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
[TBL] [Abstract][Full Text] [Related]
10. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
[TBL] [Abstract][Full Text] [Related]
11. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
[TBL] [Abstract][Full Text] [Related]
12. Oral delivery system of insulin microspheres: effect on relative hypoglycemia of diabetic albino rats.
Senthil Rajan D; Mandal UK; Veeran Gowda K; Bose A; Ganesan M; Pal TK
Boll Chim Farm; 2004 Oct; 143(8):315-8. PubMed ID: 15884295
[TBL] [Abstract][Full Text] [Related]
13. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
[TBL] [Abstract][Full Text] [Related]
14. Oral route of mini-proinsulin-expressing Ganoderma lucidum decreases blood glucose level in streptozocin-induced diabetic rats.
Ni T; Hu Y; Sun L; Chen X; Zhong J; Ma H; Lin Z
Int J Mol Med; 2007 Jul; 20(1):45-51. PubMed ID: 17549387
[TBL] [Abstract][Full Text] [Related]
15. A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats.
Cilek A; Celebi N; Tirnaksiz F; Tay A
Int J Pharm; 2005 Jul; 298(1):176-85. PubMed ID: 15950411
[TBL] [Abstract][Full Text] [Related]
16. Mucoadhesive polymers with immobilized proteinase inhibitors for oral administration of protein drugs.
Plate NA; Valuev IL; Sytov GA; Valuev LI
Biomaterials; 2002 Apr; 23(7):1673-7. PubMed ID: 11922470
[TBL] [Abstract][Full Text] [Related]
17. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
Kumar A; Lahiri SS; Singh H
Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle strategies for the oral delivery of insulin.
Damgé C; Reis CP; Maincent P
Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
[TBL] [Abstract][Full Text] [Related]
19. Investigation of lectin-modified insulin liposomes as carriers for oral administration.
Zhang N; Ping QN; Huang GH; Xu WF
Int J Pharm; 2005 Apr; 294(1-2):247-59. PubMed ID: 15814248
[TBL] [Abstract][Full Text] [Related]
20. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
